How rising COVID cases may affect Vision Expo West, Academy
Podcast: ‘Open Your Eyes’ update: Streaming options, podcasts, and part 2
‘Open Your Eyes’ update: Streaming options, podcasts, and part 2
Podcast: ODs can better connect with patients through stories
Transcript: ODs can better connect with patients through stories
ODs can better connect with patients through stories
How Eyeris helps ODs compete against disruptors
3 ways to beat disruptive competitors
COVID-19 pandemic increases myopia prevalence in children
Pandemic myopia rates are about 3x higher than prior to the virus causing lockdown
ODs: Here's what your patients tweeted about you in July 2021
Find out what your patients are tweeting about you
Poll results: What pipeline technology are you most anticipating?
See our latest poll results
J&J Vision unites operations with a solar farm to cover electricity consumption
Company will reduce greenhouse gas emissions globally by 2030
Study results show visual field loss may be an early sign of ocular hypertension
A new light shines on the management of patients with ocular hypertention
Poll: What is your first-line approach to emergent presbyopes who wear contact lenses?
This poll is for optometrists and eyecare professionals, only. It will close on Friday, August 13, 2021.
AGN-190584 is a novel treatment for patients with presbyopia
New eye drop is first designed to improve near vision
Disruptive companies continue to affect ODs
Pipeline: Presbyopia, night vision disturbance up next for Vyluma
Blackfin introduces new black edition models
Upscale optical frames added to collection
First Vyluma product tackles pediatric myopia
Vyluma pipeline focuses on refractive error
.jpeg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "AGN-190584 is a novel treatment for patients with presbyopia")
